CLN-619

· Cullinan Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CLN-619, covering 2025-09-18 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors [Phase 1]